Author: Kaitlyn Grosse

Filter by

News

New High-Tech Lab at Fred Hutch Creates 3D Maps of Proteins to Aid Therapeutics and Vaccine Research

Posted onMay 3, 2021 Last Updated: May 3, 2021
By: Kaitlyn Grosse

News

Prevencio Links with Atlas Genomics to Roll Out AI-Powered Blood Tests for Heart Disease

Posted onApril 26, 2021 Last Updated: April 26, 2021
By: Kaitlyn Grosse

Funding

Medical Device Startup Nanodropper Raises $1.4M for Eye Drop Bottle Adapter

Posted onApril 26, 2021 Last Updated: April 26, 2021
By: Kaitlyn Grosse

News

Oxford Continues Life Sciences Expansion with $119M Seattle Buy

Posted onApril 19, 2021 Last Updated: April 19, 2021
By: Kaitlyn Grosse

News

Meet the Most Innovative and Inventive Pharmaceutical Companies of 2021

Posted onApril 19, 2021 Last Updated: April 19, 2021
By: Kaitlyn Grosse

Funding

Seattle Biotech OncoResponse Raises $40.6M to Create Antibody-Based Treatments for Cancer

Posted onApril 12, 2021 Last Updated: April 12, 2021
By: Kaitlyn Grosse

Funding

Seattle Biotech Startup Outpace Bio Raises $30M to Fight Cancer with Custom-Designed Proteins

Posted onApril 12, 2021 Last Updated: April 12, 2021
By: Kaitlyn Grosse

Funding

UW Spinout Raises $100M for Vaccine Development

Posted onApril 12, 2021 Last Updated: April 12, 2021
By: Kaitlyn Grosse

News

Bothell’s Biotech Real Estate Market Stays Hot with Big Sale

Posted onApril 12, 2021 Last Updated: April 12, 2021
By: Kaitlyn Grosse

Funding

Seattle Biotech Firm Impel NeuroPharma Files for $75M IPO

Posted onApril 6, 2021 Last Updated: April 6, 2021
By: Kaitlyn Grosse